» Articles » PMID: 30389320

Effectiveness and Cost Effectiveness of Pharmacist Input at the Ward Level: a Systematic Review and Meta-analysis

Overview
Publisher Elsevier
Specialty Pharmacy
Date 2018 Nov 4
PMID 30389320
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pharmacists play important role in ensuring timely care delivery at the ward level. The optimal level of pharmacist input, however, is not clearly defined.

Objective: To systematically review the evidence that assessed the outcomes of ward pharmacist input for people admitted with acute or emergent illness.

Methods: The protocol and search strategies were developed with input from clinicians. Medline, EMBASE, Centre for Reviews and Dissemination, The Cochrane Library, NHS Economic Evaluations, Health Technology Assessment and Health Economic Evaluations databases were searched. Inclusion criteria specified the population as adults and young people (age >16 years) who are admitted to hospital with suspected or confirmed acute or emergent illness. Only randomised controlled trials (RCTs) published in English were eligible for inclusion in the effectiveness review. Economic studies were limited to full economic evaluations and comparative cost analysis. Included studies were quality-assessed. Data were extracted, summarised. and meta-analysed, where appropriate.

Results: Eighteen RCTs and 7 economic studies were included. The RCTs were from USA (n = 3), Sweden (n = 2), Belgium (n = 2), China (n = 2), Australia (n = 2), Denmark (n = 2), Northern Ireland, Norway, Canada, UK and Netherlands. The economic studies were from UK (n = 2), Sweden (n = 2), Belgium and Netherlands. The results showed that regular pharmacist input was most cost effective. It reduced length-of-stay (mean = -1.74 days [95% CI: 2.76, -0.72], and increased patient and/or carer satisfaction (Relative Risk (RR) = 1.49 [1.09, 2.03] at discharge). At £20,000 per quality-adjusted life-year (QALY)-gained cost-effectiveness threshold, it was either cost-saving or cost-effective (Incremental Cost Effectiveness Ratio (ICER) = £632/QALY-gained). No evidence was found for 7-day pharmacist presence.

Conclusions: Pharmacist inclusion in the ward multidisciplinary team improves patient safety and satisfaction and is cost-effective when regularly provided throughout the ward stay. Research is needed to determine whether the provision of 7-day service is cost-effective.

Citing Articles

Practice Guidelines for the Value Evaluation of Clinical Pharmacy Services (version 2).

Wu L, Lv Z, Chen M, Zheng X, Li L, Du S Front Public Health. 2025; 12:1472355.

PMID: 39877920 PMC: 11772294. DOI: 10.3389/fpubh.2024.1472355.


Interventions and impact of pharmacist-delivered services in perioperative setting on clinically important outcomes: a systematic review and meta-analysis.

Naseralallah L, Koraysh S, Aboujabal B, Alasmar M Ther Adv Drug Saf. 2024; 15:20420986241260169.

PMID: 39091467 PMC: 11292727. DOI: 10.1177/20420986241260169.


Informational continuity of medication management in transitions of care: Qualitative interviews with stakeholders from the HYPERION-TransCare study.

Dinh T, Hanf M, Klein A, Brueckle M, Rietschel L, Petermann J PLoS One. 2024; 19(4):e0300047.

PMID: 38573912 PMC: 10996284. DOI: 10.1371/journal.pone.0300047.


Effectiveness of clinical pharmacist interventions in optimizing pharmacotherapy for somatic comorbidities in serious mental illness: A clinical audit.

Klimentidis D Explor Res Clin Soc Pharm. 2024; 13:100427.

PMID: 38455672 PMC: 10918557. DOI: 10.1016/j.rcsop.2024.100427.


Financial impact of medication reviews by clinical pharmacists to reduce in-hospital adverse drug events: a return-on-investment analysis.

Jermini M, Fonzo-Christe C, Blondon K, Milaire C, Stirnemann J, Bonnabry P Int J Clin Pharm. 2024; 46(2):496-505.

PMID: 38315303 PMC: 10960916. DOI: 10.1007/s11096-023-01683-w.